Antimalarial drug combination policy: a caveat.

Antimalarial drug combination policy: a caveat.

Item
http://www.wikidata.org/entity/Q41921517
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderResponding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practiceIncreasing antimalarial drug resistance in Uganda and revision of the national drug policy.Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.History, dynamics, and public health importance of malaria parasite resistance.Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.Existing antimalarial agents and malaria-treatment strategies.Community perceptions of a mass administration of an antimalarial drug combination in The Gambia.In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria.
P2860

Antimalarial drug combination policy: a caveat.

Item
http://www.wikidata.org/entity/Q41921517
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Antimalarial drug combination policy: a caveat.
@en
type
label
Antimalarial drug combination policy: a caveat.
@en
prefLabel
Antimalarial drug combination policy: a caveat.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Antimalarial drug combination policy: a caveat.
@en
P2093
P304
P31
P356
10.1016/S0140-6736(00)02416-8
P407
P433
P478
P577
P698
P921